Sintx Technologies, Inc. (SINT) research

Sintx Technologies, Inc.

Sector: Healthcare
Industry: Medical Devices
Last price: $2.21
As of: 2026-10-02

Sintx Technologies, Inc. (SINT): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-01.

As of 2026-10-01, the latest of: this ticker's 13F holdings load, its latest SEC filing date, and its latest signal other than 13F-derived signals. Source: SEC EDGAR filings for SINT. Method and limitations.

COMPANY DOSSIER

See the full SINT dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for SINT on one page. Preview it with sample data, then open it live with a free account.

Preview the SINT dossier

Active signals for SINT

highINSTITUTIONAL_SURGE2026-08-16
CITADEL ADVISORS LLC added +137% to SINT (2026Q2)
All 2026-08-16 signals →
mediumEARNINGS_MISS2026-08-12
Q2-2026: Missed consensus by 9.2%, EPS $-0.75 vs $-0.6868 estimate
All 2026-08-12 signals →
mediumEARNINGS_MISS2026-06-21
Q3-2025: Missed consensus by 516.8% - EPS $-3.46 vs $-0.561 estimate
All 2026-06-21 signals →
mediumEARNINGS_MISS2026-05-17
Q2-2025: Missed consensus by 12.9% - EPS $-0.91 vs $-0.8058 estimate
All 2026-05-17 signals →
mediumEARNINGS_MISS2026-05-17
Missed consensus by 516.8% - EPS $-3.46 vs $-0.561 estimate
All 2026-05-17 signals →

FREE, NO ACCOUNT

Every signal on SINT, as it fires

New filings, 13F moves and cross asset signals on SINT land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in SINT (2026Q2)

Manager / security	Market value	% portfolio	QoQ
CITADEL ADVISORS LLCCUSIP 829392703 · 2026Q2	$60K	0.00%	,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, SINT

8-K2026-10-01
SEC EDGAR ↗
8-K2026-08-13
SEC EDGAR ↗
10-Q2026-08-11
SEC EDGAR ↗
8-K2026-08-11
SEC EDGAR ↗
8-K2026-07-23
SEC EDGAR ↗
8-K2026-07-02
SEC EDGAR ↗
8-K2026-06-03
SEC EDGAR ↗
8-K2026-05-27
SEC EDGAR ↗
10-Q2026-05-15
SEC EDGAR ↗
10-K2026-03-20
SEC EDGAR ↗

SINT against its peers

SINT's operating margin of -1053.1% ranks in the 32nd percentile of 16 Medical Devices sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-05-31.

Metric	SINT	Peer median	Percentile	n
Revenue FY	1.0M USD	1.6M USD	40	20
Revenue YoY	n/a	-15.3%	n/a	6
Gross margin	45.3%	47.8%	50	18
Operating margin	-1053.1%	-288.8%	32	16
Net margin	-1018.1%	-416.7%	33	19
Return on equity	-353.8%	-154.9%	18	18

Peers (22): CTSO, PLSM, ALRTF, BMRA, IRIX, PMI, MODD, GTHP, TANAF, LFWD, HSCS, WOK, RDGL, CODX, ICCM, AMIX, BDMD, VNRX, FOFA, NVNO, PETV, NSYS. Left out: NMTC (no annual filing), SONX (period gap), KLYG (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (SINT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more SINT signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to SINTand get the insider, 13F, options, and confluence read in one view.